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Summary Adrenal infections are an important but under-recognized clinical entity. The
adrenal gland can be infected by a myriad of pathogens including fungi, viruses, parasites,
and bacteria. Infection can directly or indirectly cause tissue damage and alteration in endocrine
function. Direct damage occurs via microbial replication and local production of toxic com-
pounds, such as endotoxins. Indirect damage results from alterations in the regulation of a host’s
immunologic and endocrine mediators in response to damage by a microbe at a distant site.
Variations in pathogen tropism, adrenal anatomy, and host immune integrity contribute to the
progression of active disease and discernable adrenal dysfunction. Early recognition and inter-
vention in the case of adrenal infection can significantly improve outcome, demonstrating the
need for increased clinical suspicion in the appropriate clinical setting.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
Infections of the adrenal gland are an important yet rela-
tively uncommonly recognized clinical entity. Although auto-
immune destruction represents the primary cause of adrenal
dysfunction in developed countries (80—90%), infectious
etiologies represent the major cause of Addison’s disease
in the developing world, with Mycobacterium tuberculosis
being the most common causative agent.1 The adrenal gland
can be directly infected by various microbial pathogens,
including a diverse array of viruses, fungi, and bacteria.1
Immunocompromised individuals are at greatest risk for
either primary adrenal infection or disseminated microbial
disease involving the adrenal gland. However, numerous case* Corresponding author. Tel.: +1 718 430 2366; fax: +1 718 430 8968.
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doi:10.1016/j.ijid.2005.08.001reports describe individuals with objectively normal immune
function who nonetheless have clinical or pathological evi-
dence of primary adrenal involvement in the setting of an
indolent infection.2—16
Due to the non-specific nature of the symptomatology and
laboratory manifestations (e.g., fatigue, anorexia, low blood
pressure, hyperkalemia, hypernatremia, hypoglycemia1) and
the fact that 80—90% of the gland must be destroyed before
the patient will demonstrate overt Addisonian symptoms,17
antemortem diagnosis is rare. However, prompt recognition
combined with appropriate therapy early in the disease
course may prove beneficial,13,15,16,18—20 thereby warranting
a high clinical suspicion for adrenal involvement in the
appropriate clinical scenario.
Adrenal dysfunction can also occur in response to infec-
tions at distant sites or in disseminated disease due to
alterations in the host’s physiochemical milieu.14—16,18—32
It is generally understood that individuals who are respondingPublished by Elsevier Ltd. All rights reserved.
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manifest an increase in the functioning of the hypothalamo-
pituitary—adrenal axis (HPA-axis) leading to an overall
increase in systemic corticosteroid levels. Increased cortisol
secretion has been shown to shift the balance in the Th1/Th2
cell ratio towards a Th2 response.21,33 This shift, along with
age-related changes in dehydroepiandrosterone (DHEA), is
thought to enhance the infectivity of M. tuberculosis (where
a Th1 dominated response is considered to be protective) and
a cycle of positive immunological alterations is induced to the
benefit of the bacteria. In addition to the up-regulation of the
HPA-axis to secondary infection, endotoxin and exotoxins can
induce both functional and pathological changes to the
adrenal gland.32,34
In addition toM. tuberculosis, hypercortisolism,both endo-
genous or due to the administration of high dose corticoster-
oids, is associatedwith a significant increased risk for infection
with Nocardia asteroides, Aspergillus spp, Cryptococcus neo-
formans, and Pneumocystis (carinii) jirovecii.35—48 Additional
organisms associated with disease in the setting of high sys-
temic cortisol levels include Strongyloides stercoralis,49,50
Staphylococcus aureus,41,51 Histoplasma capsulatum,52 and
mycobacterial disease, such as M. tuberculosis53,54 or Myco-
bacterium chelonae.55 Importantly, the signs and symptoms of
disease can be obscured by the hypercortisolism. The
increased incidence of serious infections in the setting of
hypercortisolism is due to the complex deregulation of the
normal inflammatory response, such as alterations in cytokine
production, decreased migration of effector cells to sites of
inflammation, and impaired cytotoxic functions (reviewed
in56), resulting in an inability of the host to effectively combat
invading pathogens.
In glandular infection, variations of the particular tropism
of the implicated agent determine the differential rates of
adrenal involvement from organism to organism regardless of
host immune integrity (this is however tobedistinguished from
glandular destruction). For example, autopsy studies have
shown that adrenal involvement occurs in 85—90%16,57 of
infections due to Paracoccidioides brasiliensis, a dimorphic
fungus, regardless of host immune status. However, clinical
symptomatology and overt adrenal dysfunction were found in
only 14—20%16,58 of individuals with P. brasiliensis adrenal
infection, suggesting a possible variation in either the viru-
lence and destructivity of the organism or, potentially, in host
immune responses. The interaction between an endogenous
host response andmicrobial growth and/or antigenproduction
influences the destructive capabilities and disease manifesta-
tions of a particular microorganism.59
Pathological effects of infection
Microbes affect the adrenal glands either by direct invasion
of tissue substrate or via secondary mediators through down-
stream pathways and biochemical modulators. The interplay
of endotoxin produced locally or from a distant source and
adrenocorticotrophin (ACTH) set up conditions that predis-
pose the adrenal gland to hemorrhage and, potentially, the
Waterhouse—Friderichsen syndrome. The Waterhouse—Fri-
derichsen syndrome represents a paradigm for the interre-
lationship of host and microbe within the adrenal gland with
the disease being characterized by acute adrenal glandinsufficiency and profound shock. The syndrome is typically
attributed to infection with Neisseria meningitidis,18 but it
may occur in fulminant infections with other microbes,
including smallpox.60 In his pioneering clinical and laboratory
work, Friderichsen described the Waterhouse—Friderichsen
syndrome in cases due to N. meningitidis, Streptococcus spp,
Haemophilus influenzae, Corynebacterium diphtheriae, and
Staphylococcus aureus, and he was able to experimentally
induce adrenal hemorrhage in guinea pigs by injections of
Bacillus anthracis, Clostridium tetani, Streptococcus spp and
several Gram-negative bacilli.61
The anatomical distribution of vessels to the adrenal
makes the gland particularly prone to hemorrhage in the
setting of increased venous pressure.14 In a study conducted
upon rabbits, Levin and Cluff62 discovered that the local or
systemic administration of endotoxin resulted in adrenal
hemorrhage, but only after priming with ACTH. ACTH causes
increased blood flow to the adrenal,14 which suggests that a
hyperactive gland is a necessary predisposing condition for
hemorrhage. Other studies of Waterhouse—Friderichsen
cases have demonstrated changes in the cortices, such as
compact cells, pseudotubules, and degenerate cortical cells,
as well as extensive deposition of fibrin thrombi in many
organs including the adrenal, indicating a role of dissemi-
nated intravascular coagulation (DIC) in the syndrome.63
However, case reports exist with no overt clinical evidence
of DIC,30 suggesting that the effects of ACTH and endotoxin
are sufficient to induce the hemorrhagic syndrome. In addi-
tion to endotoxin, exotoxin has been studied and shown to
have distinct pathological effects upon the adrenal gland.
Kuwajima32 injected sensitized rats with the histamine sen-
sitizing factor (HSF) of Bordetella pertussis which resulted in
cytolysis, vacuolation, cellular necrosis, and lipid depletion
in the adrenal zona fasciculata.
The predilections of certain fungi for the adrenals and their
pathological effects on the gland have been studied. P. bra-
siliensis primarily causes destruction by embolic infection of
small vessels by large fungal cells, leading to endovasculitis
and granuloma formation. Caseationnecrosis is responsible for
the largest loss of glandular tissue and it is most likely a
consequence of local tissue ischemia secondary to the fungal
emboli.16,57,64 The high local concentrations of corticosteroids
have been postulated to account for the tropism of H. capsu-
latum for the adrenals.65 H. capsulatum adrenal lesions are
found most commonly in the zona reticularis where there are
elevated levels of corticoids downstream from the area of
secretion, zona fasciculata to the medullary venous sys-
tem.15,65 The development of adrenal vasculitis can cause
extensive glandular destruction resulting in frank adrenal
insufficiency.66 As in P. brasiliensis, the affected vessels are
unable to adequately perfuse adrenal tissue, leading to casea-
tion necrosis and massive glandular infarction.
Physiochemical effects of infection
Microbial infection alters the biochemical and endocrinologic
milieu of the host. Alterations in the functioning of upstream
endocrine regulators and/or downstream hormonal media-
tors can feedback upon the adrenals and cause an upregula-
tion in HPA-axis function that increases the amounts of
circulating corticosteroids.20,27,34,67 It has been demon-
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activation of the HPA-axis, mainly due to a release of the
cytokines IL-1, IL-6, and TNF-a from stimulated peripheral
immunecells initially actingdirectly oncorticotropin releasing
factor (CRF).34 In human sepsis, the HPA-axis is upregulated
resulting in elevated cortisol levels and, in the acute phase, is
associated with increased ACTH release.34 When sepsis is
protracted the patient enters a ‘stress-conditioned’ stage of
HPA-axis adaptation wherein ACTH is low and overall plasma
cortisol is elevated suggesting a direct role of immunological
mediators upon the adrenal gland. Along with the increase in
glucocorticoids, there is a concomitant decrease in the level of
androgens and mineralocorticoids with dissociation between
the reduced aldosterone secretion and elevated renin level.
However, numerous studies have questioned whether or not
persistently elevated plasma cortisol represents an adequate
response to the protracted illness or if the HPA-axis is inade-
quately responding to the prolonged stress.68,69 There are
indications that during protracted critical illness there is a
relative adrenocortical insufficiency despite normal or ele-
vated total serum cortisol levels,34 and the incidence of
adrenal insufficiency in septic patients is high.70
The HPA-axis is frequently disturbed in tuberculosis.
Administration of the M. tuberculosis cell-wall component
lipoarabinomannan (LAM), mycobacterial heat shock protein-
65 KD, or M. tuberculosis culture filtrate produces a similar
response in normal hosts to that elicited by lipopolysacchar-
ide (LPS).21 During active pulmonary tuberculosis measure-
ments of basal cortisol levels and responses to ACTH
stimulation have shown that cortisol reserve is normal or
increased in patients with active disease. Patients with more
extensive pulmonary disease havemore significant changes in
cortisol diurnal variation than those with limited disease
suggesting that the adrenals are more responsive to active
disease.21,71,72 The cytokine that appears to be produced in
greatest amounts is TNF-a, which stimulates macrophage
aggregation and granuloma formation to contain the bac-
teria73 while simultaneously activating the HPA-axis. The
upregulation in the HPA-axis and subsequent rise in cortisol
levels promotes a predominantly Th2 response. In addition to
the protracted stress response inducing a decrease in andro-
gen production, increasing age causes declining DHEA(S)
levels so that by the time an individual is 80 years old
concentrations are about 25% of those at age 25.74 Low levels
of DHEA(S) often occur in patients with tuberculosis, suggest-
ing a role for both increased cortisol and decreased andro-
gens in the pathogenesis of the disease.21,75 The interplay
between infection, endocrine function, and immunomodu-
latory cytokines dictates the overall response both systemi-
cally and locally at the adrenal level thereby delineating the
role of the HPA-axis and adrenal hormones in general in
causing disease both in the adrenal gland and at distant sites.
Viruses
Infection with the human immunodeficiency virus (HIV) pre-
disposes individuals to numerous other infections, including
viral diseases such as cytomegalovirus (CMV), that result in
adrenal infection and dysfunction.1,24,25,29,76—78 However,
direct destructionof theadrenal byHIV is unusual.79 In autopsy
studies, the adrenal gland is the most commonly involvedendocrine organ in patients with HIV.80,81 One autopsy study
of 128 patients with AIDS demonstrated that the adrenal gland
waspathologically compromised in99.2%of the subjects.78 It is
estimated that adrenal insufficiency occurs in 5—8% of HIV-
infected individuals, which is substantially higher than the
incidence in the general population.29 In addition to direct
infection byHIV,82 proposed etiologies for adrenalmalfunction
include opportunistic infections (i.e., CMV), AIDS-associated
neoplasms (i.e., Kaposi sarcoma, non-Hodgkin’s lymphoma),
hemorrhage, viral-induced autoimmune destruction, and
adverse effects of chemotherapeutics.29
From autopsy studies, CMV appears to play the most
significant role in adrenal damage during HIV infection.
One study of adrenal pathology in 41 patients with AIDS
showed that CMV was the most common infection seen in
the adrenal gland, occurring in 21 cases (51%).25 Similarly,
additional postmortem studies focusing on adrenal pathology
in 2577 and 12878 AIDS patients revealed that CMV adrenalitis
occurred in 56% and 48.4%, respectively. In individuals with
AIDS, CMV is usually disseminated, but CMV adrenalitis may
occur without clinical evidence of dissemination.83 CMV
appears to cause a mixed inflammatory infiltrate with the
cortex—medulla junction being the area of greatest
injury,24,78 and the amount of necrosis in the region is directly
correlated with the degree of direct CMV involvement.25 In
spite of the extensive involvement of CMV in the adrenal
gland of HIV-infected patients, antemortem diagnosis
remains a rare occurrence.77 The discordance is most likely
due to the stimulation of the HPA-axis and the need for near
total glandular destruction before clinical symptoms become
obvious. Studies have shown that as few as 26% of patients
have correctly diagnosed antemortem CMV adrenalitis.77
Disturbance of adrenal function can occur at all stages of
HIV infection. Though clinically silent, elevation of ACTH and
cortisol levels occurs early in infection.20 As HIV infection
progresses, overt and clinically apparent insufficiency can
occur with normal to low ACTH levels.20 As in endotoxemia,
the early rise in basal cortisol appears to be an adaptive
response to a stressor. In addition, advancing HIV infection
increases the cortisol-binding globulin (CBG) in the serum in
response to stimulation of the adrenal cortex by IL-1b and IL-
6.26 In advanced HIV disease, adrenal ‘burnout’, co-infection
by opportunistic microbes, anti-adrenal cell antibodies
(unique to HIV infection),84 and increased peripheral cortisol
resistance are all posited as mechanisms to explain the
progression to overt adrenal failure.20,26,27 Interestingly,
there is a case report of an individual with AIDS undergoing
treatment for Pneumocystis pneumonia who developed adre-
nal failure due to CMV in the setting of the administration of
high doses of exogenous steroids.85 As in tuberculosis, the
shift towards cortisol production and away from androgen
may enhance the induction of Th2 type responses while
inhibiting protective Th1 responses thereby advancing HIV
infection86 and disease due to co-infecting viruses.
The actual incidence of adrenal insufficiency in HIV-
infected patients varies from study to study and depends
upon the parameters used to assess adrenal function and the
HPA-axis, Center for Disease Control (CDC) staging of HIV
infection, and clinical status of the patient. Estimates place
the overall incidence of adrenal insufficiency between 5% and
8%, with CMVremaining themost likely exacerbating agent.87
A prospective study of 60 patients with advanced AIDS (CD4
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Figure 1 Representative images of (A) acute and (B) chronic adrenalitis. (A) Acute adrenalitis: normal adrenal cortex (top) and focal
necrosis. (B) Chronic adrenalitis with lymphocytic infiltration. Examples are from two cases of systemic herpes virus infection. Tissue
was stained with hemotoxylin and eosin (magnification: 40).<50), found that 25% had adrenal dysfunction at baseline and
these patients all had detectable CMVantigenemia.19 Follow-
up of 34 of the patients revealed that 16 (47%) progressed to
overt adrenal insufficiency.19 A separate study of 30 AIDS
patients found a significant correlation between adrenal
insufficiency and the presence of CMV retinitis and CMV
antigenemia.23
Controversy exists as to the appropriate diagnostic para-
meters for a screening test to delineate possible adrenal
insufficiency, which likely accounts for some of the dispa-
rities in numbers of cases reported by different authors.20
Screening in HIV-infected individuals has proven to be com-
plex.88 This is evident in a study of 28 critically ill HIV patients
screened with both a low-dose ACTH (LD-ACTH) and high-
dose ACTH (HD-ACTH) using both<18 mg/dl and<25 mg/dl of
cortisol as a cutoff to define an abnormal response to the
test.27 With a stress cortisol of <18 mg/dl, 50% of patients
screened positive for adrenal insufficiency, whereas changing
the diagnostic threshold to <25 mg/dl resulted in a positive
test for adrenal insufficiency in 75% of patients. The results
varied from 7% to 46% with the addition of the LD-ACTH and
HD-ACTH to the assessed parameters, highlighting the decep-
tive nature of adrenal diagnostics and inter-test variability.
Certain viruses have mutagenic potential. In particular,
Epstein—Barr virus-associated lymphoma of the adrenal gland
has also been reported.89—93 The majority of these cases have
been in individuals infectedwithHIV. Interestingly, the adrenal
deregulation of glucocorticoid levels that often occurs in HIV
infected patients may significantly increase reactivation of
latent Epstein—Barr virus.94 Adrenalitis can also occur during
acute Epstein—Barr virus infection.95
Additional relatively common viruses can also cause sig-
nificant adrenal disease in certain clinical settings. For
example, neonatal infections with echoviruses, particularly
serotypes 6 and 11, are associated with lethal disseminated
intravascular coagulation resulting in severe damage to mul-
tiple organs, including adrenal hemorrhagic necrosis.96—101
Herpes simplex virus (HSV) (Figure 1) similarly can cause
damage to the adrenals in fulminant disease in neonates.102
However, apparently immunologically intact individuals can
have adrenal infection due to HSV.103 Interestingly, experi-mental data from mice suggests that the rapid infection of
the central nervous system during primary HSV type 1 or 2
occurs via the adrenal gland.104—106 Early in HSV type 1 and 2
infection, the adrenal glands frequently contain the highest
number of viral particles of any organ.107
Other less common hemorrhagic viruses also have a high
potential for catastrophic adrenal disease. Lethal infections
with filoviruses, such as Ebola virus, are characterized by
massive apoptotic lysis of cells in multiple organs including
liquefaction of the adrenals.108 Although the Marburg viruses
have a lower case fatality rate, they too can cause damage to
the adrenal, particularly the cortical cells.108,109 Similarly,
Lassa virus, an arenavirus, has been shown to infect the
adrenals.110
Adrenal involvement can also occur during infection with
the relatively recently identified severe acute respiratory
syndrome associated coronavirus (SARS-CoV).111 However,
the cellular abnormalities seen in the adrenal could be
due to direct cytopathic effects by the virus or due to
systemic inflammatory responses. Interestingly, SARS-CoV
deregulates the host’s corticosteroid stress response by pro-
ducing peptides that are molecular mimics of ACTH.112 Anti-
bodies to the viral peptides bind both viral protein and host
ACTH, which reduces the host’s ability to secrete corticos-
teroids, resulting in a state of adrenal insufficiency. It has
been postulated that the administration of glucocorticoids in
SARS-CoV infection may abrogate or otherwise modify infec-
tion.112 It is also noteworthy that influenza virus type A
infection can affect the production or release of ACTH.113
Prior to the availability of cortisone, influenza virus (parti-
cularly Asian influenza) was typically fatal in patients with
adrenal insufficiency.114 There is recent experimental evi-
dence to suggest that the highly pathogenic H5N1 avian
influenza A viruses currently circulating in Southeast Asia
have the capacity to cause severe adrenal damage, since they
cause multifocal necrosis of adrenal cells in some fowl
species.115 However, an autopsy study of a single patient
who died of H5N1 influenza only detected viral RNA by
reverse transcription-polymerase chain reaction in lung,
intestine, and spleen, with viral replication being localized
only to the lung.116
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Many pathogenic fungi are known to affect the adrenal glands
in both immunocompetent and immunocompromised indivi-
duals, with the highest incidence occurring in individuals
with defects in cell-mediated immunity. Adrenal infection
most frequently occurs in the setting of disseminated infec-
tion. In endemic areas, pathogenic fungi can cause higher
rates of adrenal insufficiency than any other infectious etiol-
ogy. For example, up to half of patients with severe, dis-
seminated H. capsulatum infection have been found to have
an infected adrenal gland.9,15 It is postulated that the reason
for the tropism of H. capsulatum for the gland is the local
production and release of glucocorticoids and a relative lack
of reticuloendothelial cells within the adrenal.117 Destruc-
tion of the gland itself is thought to occur via direct infection
by H. capsulatum leading to an extracapsular and intracap-
sular vasculitis causing local ischemia and caseation.15 Typi-
cal adrenal involvement occurs during disseminated infection
and is frequently bilateral with radiographic evidence of
suprarenal masses, however, unilateral involvement has also
been described.8,9,15 Though histoplasmosis typically occurs in
endemic areas, cases occur worldwide.9 Autopsy data from
several studies of disseminated H. capsulatum have described
adrenal involvement in30—50%9,15 of the cases, however there
remains a discordance between postmortem pathological
diagnosis and antemortem clinical suspicion.15 The rate of
clinical adrenal insufficiency in patients with adrenal histo-
plasmosis is estimated to be between 5% and 50%.9,118 There is
evidence that early antifungal therapy can lead to at least
partial recovery of adrenal function,119 though most cases
require long-term corticosteroid maintenance.15
P. brasiliensis is a dimorphic fungus endemic to Brazil and
other South American countries. Paracoccidioidomycosis
(PCM) is a chronic, progressive, suppurative and granuloma-
tous disease that often leads to adrenal involvement.7
Autopsy studies have demonstrated adrenal involvement in
44—80% of the studied cases,120,121 with frank adrenal dys-
function noted in 14—44% of affected patients.16 Although
calcifications may be detected by computed tomography,2
near complete destruction of the gland can occur without
calcification.6 Importantly, patients with disseminated PCM,
adrenal dysfunction, and Addisonian symptoms who receive
antifungals over a 1—2 year period may fully recover adrenal
function.16 Antifungal therapy, if prescribed in the early
stages of the disease is thought to prevent fungal embolism
thereby reestablishing blood flow and reducing adrenal
necrosis and progression to adrenal dysfunction.64 In spite
of the substantial rates of adrenal involvement in PCM, the
clinical suspicion for adrenal insufficiency is often low as the
symptomatology may be attributed to the systemic mycosis.6
The efficacy of early intervention in preventing the progres-
sion to adrenal dysfunction warrants an increased clinical
suspicion of adrenal involvement in patients presenting with
signs and symptoms of PCM.
Like the other dimorphic fungi described above, Blasto-
myces dermatitidis has a high affinity for the adrenal gland,
however, it does not appear to cause a similar rate of overt
adrenal failure. Radiographs demonstrate bilaterally enlarged
adrenal glands in most cases of adrenal involvement.122
Autopsy studies have demonstrated a 10% involvement of
the adrenal gland in cases of disseminated blastomycosis.123However, the patients did not have an antemortem or post-
mortem diagnosis of adrenal failure. In a review of 90 patients
with blastomycosis, only one patient with symptoms consis-
tent with adrenal insufficiency was discovered.124 However,
there are case reports describing patients with Addison’s
disease caused by blastomycosis.122,125
C. neoformans is an encapsulated yeast-like fungus that
typically infects immunodeficient patients, particularly indi-
viduals with advanced AIDS. Despite the propensity of this
fungus to cause disseminated disease, adrenal dysfunction is
uncommon.13 However, as with blastomycosis, case reports of
primary adrenal cryptococcosis causing adrenal failure
exist.5,12 Autopsy studies on AIDS patients have demonstrated
adrenal cryptococcosis in up to 5.5% of cases.78 It appears that
near total replacement of the adrenal gland with C. neofor-
mans and caseating granulomas are necessary for adrenal
dysfunction to become clinically apparent.5 Apparently immu-
nologically competent individuals may also develop crypto-
coccosis involving the adrenal gland.4,12 Infection may consist
of an isolated lesion with no obvious adrenal dysfunction4 or
can result in disseminated cryptococcosis and adrenal failure
duetodirect infectionof the fungus.12There is evena reportof
cryptococcosis in a patient with apparently intact cell
mediated immunity whose adrenal glands served as a source
for persistent fungemia despite appropriate antifungal ther-
apy that only resolved with bilateral adrenalectomy.126
Pulmonary infections with P. (carinii) jirovecii occur in
individuals with defects in Th1 cell immunity, as in the case of
advanced HIV. Additionally, visceral dissemination can occur,
including to the adrenal glands. For example, two of nine
patients with AIDS and visceral calcifications secondary to P.
jirovecii were shown to have adrenal disease.127 Visceral
sites may shield P. jirovecii from antifungal therapy setting
up a source for recurrent pulmonary infections.128 The rate of
adrenal dysfunction due to direct involvement of the fungus
appears to be low, but even an apparently immunologically
intact individual with isolated adrenal involvement can
develop a fatal Addisonian crisis.129 Additional mycoses asso-
ciated with adrenal failure include coccidioidomycosis130,131
and candidiasis.132
It is noteworthy that a major category of antifungal
medications, the azoles, can adversely affect adrenal func-
tion presumably via liver cytochrome P450-mediated inter-
actions. In particular, the inhibition of CYP3A4 (the most
abundant cytochrome P450 in humans) significantly impacts
steroid catabolism.133 The most potent antifungal that inhi-
bits the P450 system is ketoconazole (an azole that currently
is infrequently used in the USA and Europe), but adrenal
insufficiency can occur during the administration of other
azoles.134—137 Additional important inhibitors of the P450
system include antibacterials (such as macrolides and iso-
niazid) and antiviral agents (such as ritonavir and delavir-
dine). Hence, clinicians should carefully consider the
potential risks associated with the use of an azole or other
medications that affect glandular function in patients at risk
for, or with suspected or proven, adrenal dysfunction.
Bacteria
Bacteria can affect the adrenal gland by direct infection and
tissue damage, by the production of exotoxins or endotoxins,
348 W.F. Paolo Jr, J.D. Nosanchukand by deregulation of the physiological host response. M.
tuberculosis is the most common bacterial agent associated
with adrenal destruction. The mycobacterium disseminates
to the adrenal gland hematogenously, where it can reside
without clinical symptomatology for up to 10 years.21 In a
large retrospective study of 13 762 patients, active tubercu-
losis was found in 6.5% of all cases with 6% of the patients with
active M. tuberculosis disease demonstrating adrenal insuf-
ficiency.138 In 25% of the patients with adrenal involvement
the infection was restricted to the adrenal gland. Interest-
ingly, M. tuberculosis appears to cause direct adrenal dys-
function by inducing degeneration of cells within the adrenal
cortex.71 The radiographic appearance of the adrenal gland
correlates with the length and activity of the tuberculosis
within the gland. Large glands occur in recent active infec-
tion whereas small, atrophied, or calcified glands appear to
represent inactive or remote infection.71 Studies have
attempted to discern whether treatment at any of the radio-
graphic stages of disease improves adrenal function. A study
that looked at tuberculosis patients with bilaterally enlarged
adrenal glands and frank Addisonian crisis found that treat-
ment with anti-tuberculosis drugs does not improve or help
recover adrenal functionality.139 In addition, treatment with
rifampin, itself an inducer of hepatic enzymes that metabo-
lize glucocorticoids, can cause an individual with a stressed
HPA-axis and minimal cortisol reserve to enter into Addiso-
nian crisis, warranting careful monitoring of critically ill
tuberculosis patients. The atypical mycobacterium Mycobac-
terium avium can involve the adrenals of AIDS patients, with
one study finding the organism in five out of 41 cases.25
Although adrenal failure may occur, infiltrative disease has
been reported without clinically apparent dysfunction.140
The role of M. avium in adrenal disease is uncertain and
most adrenal destruction is thought to be due to concomitant
infection with CMV and not by direct effects of the myco-
bacterium.
As mentioned above, Waterhouse—Friderichsen syndrome
is a rapidly progressing entity in which bacterial sepsis
appears to induce bilateral adrenal hemorrhage. The most
common etiological agent associated with the syndrome is
the bacteria N. meningitidis,18 however it can also occur
during systemic disease due to group A streptococcus, pneu-
mococci, Haemophilus influenzae, Klebsiella oxytoca, Cap-
nocytophaga canimorsus, Pasteurella multocida, and
Ewingella americana.11,14,30,31,141—148 Though the bacteria
associated with the syndrome are rarely found in the patho-
logical adrenal specimens of the patients who die during this
syndrome, it is felt that the bacteria must also reside in the
adrenal tissue and that it is most likely not demonstrated
secondary to the heavy use of antibiotics antemortem. The
disorder is thought to be brought about by the stressed
adrenals response to endotoxin precipitating a local DIC in
a physiologically altered gland.
Parasites
Parasitic infections of the adrenal gland are rare occurrences
with frequency rates dependant upon the organism, resi-
dence in endemic areas, and host immune integrity. Case
reports have demonstrated adrenal involvement with such
diverse pathogens as Microsporidia spp,149,150 amebic spe-cies,151 Trypanosoma spp,152,153 Leishmania spp,154,155 and
Echinococcus spp.156,157 The nature of involvement of the
adrenal gland varies significantly depending on the microbe.
Echinococcus spp cause hydatid disease, which presents with
diffuse cystic involvement of visceral organs. The most com-
monly involved organs are the lungs and liver, with adrenal
involvement representing 0.5% of studied cases,156,157
usually as part of a generalized infection and, more rarely,
as primary cysts. It is estimated that hydatid disease accounts
for 6—7% of all diagnosed cases of adrenal cysts.156,157 Visc-
eral leishmaniasis can also cause cystic adrenal disease, both
in immunocompetent155 and immunocompromised indivi-
duals.154 Rarely, amebic species have been found in cystic
lesions of the adrenal gland. For example, there is a case
report of a previously healthy Mexican patient presenting
with Balamuthia mandrillaris encephalitis, in which amebic
trophozoites were incidentally observed in the left adrenal
gland during postmortem examination.151 In immunocompro-
mised patients (particularly in individuals with AIDS) various
species of microsporidia cause a wide array of pathological
features ranging from localized infection of the gastrointest-
inal tract to a diffuse visceral infection mimicking other more
commonly diagnosed opportunistic infections. Adrenal invol-
vement in disseminated microsporidia induces large necrotic
lesions with histiocytic and fibrotic reactions within the gland
substrate.149,150 In infections due to Trypanosoma cruzi, the
adrenal may serve as a reservoir for the organism.152,153 In
fact, investigators have correlated infection within the cen-
tral vein of the adrenal gland and the development of
chagasic myocarditis.152,153
Conclusions
The adrenal gland can be infected by a multitude of patho-
genic microorganisms that not only exert detrimental effects
on the organ by local tissue destruction but also through
disturbances in the homeostasis of the host’s HPA-axis.
Recent advances in clinical studies have demonstrated a role
for low dose corticosteroid replacement in individuals with
vasopressor-dependant septic shock regardless of overall
adrenal function.158—160 Several recent comprehensive
meta-analyses and reviews have concluded that low dose
steroids should be used in this setting.158—160 Clinical trials
published prior to 1989 demonstrated a distinct survival
disadvantage in enrolled patients given corticosteroid repla-
cement.158 However, most of these trials used an ineffective
high dose replacement regimen (defined as 30 mg/kgmethyl-
prednisolone or equivalent steroid preparations adminis-
tered up to four times during a short course of 1 or 2 days)
as opposed to a low dose regimen (defined as a daily dose of
200—300 mg of hydrocortisone or equivalent administered
for 5—7 days or longer).159 Recent studies using the revised
‘low-dose’ replacement dosing of corticosteroids, with the
greatest benefit demonstrated with hydrocortisone, have
shown a significant survival advantage in individuals suffering
from vasopressor-dependant septic shock but not pure sepsis
in the absence of shock (relative benefit range 1.13—3.24,
95% CI 0.86—7.01).158,159 Low dose treatment should be
begun as early as possible, but positive effects may be seen
in patients with late septic shock. Similar to assessment in
individuals with HIV infection, adrenal function testing in
Adrenal infections 349critically ill patients has not been shown to be a reliable
predictive tool to determine the potential efficacy of repla-
cement steroids regardless of overt adrenal insufficiency or a
defined relative adrenal insufficiency.159
By continuing to advance studies that delineate the nature
of adrenal infections and the interplay between host
response and disease progression, the myriad disparate
infectious entities that culminate in adrenal pathology can
better be clinically addressed. Innovations in laboratory
diagnostics, such as PCR,161 and improvements in imaging
techniques,162,163 including computed tomography—fine-
needle aspiration biopsy,164 increase the ability of clinicians
to diagnose indolent infection processes earlier. Improved
methods for diagnosing adrenal function in diverse popula-
tions are urgently needed. Though infections of the adrenal
gland continue to be under-recognized, the possible benefits
of early recognition and intervention, particularly for fungal
pathogens, warrant increased clinical suspicions especially
during systemic infections.
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